Galecto (GLTO) to Release Earnings on Friday

Galecto (NASDAQ:GLTO) is projected to post its quarterly earnings results before the market opens on Friday, March 14th. Analysts expect Galecto to post earnings of ($2.97) per share for the quarter.

Galecto Trading Up 1.0 %

GLTO stock opened at $4.05 on Thursday. The company’s 50 day moving average is $4.84 and its two-hundred day moving average is $6.91. The stock has a market cap of $5.33 million, a P/E ratio of -0.21 and a beta of 1.18. Galecto has a twelve month low of $3.76 and a twelve month high of $21.06.

About Galecto

Galecto, Inc, a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB2064, a selective oral small molecule inhibitor of LOXL2 that is in Phase 2a clinical trial for the treatment of fibrotic diseases, including cancer and myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis.